Literature DB >> 4058537

Effect of erythromycin on cyclosporine levels.

R J Ptachcinski, B J Carpenter, G J Burckart, R Venkataramanan, J T Rosenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4058537     DOI： 10.1056/nejm198511283132214

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.

Authors:  Xiangfeng Zeng; Tong Wang; Cairong Zhu; Yanxia Ye; Bing Song; Xinqiang Lai; Yaoying Zeng
Journal:  Inflamm Res       Date:  2012-03-10       Impact factor: 4.575

Review 2.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients.

Authors:  R Guillemain; E Billaud; G Dreyfus; C Amrein; M Kitzis; V A Jebara; C Kreft-Jais
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

5.  Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.

Authors:  M Kessler; P Netter; M Zerrouki; E Renoult; P Trechot; B Dousset; B Jonon; J M Mur
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 6.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

7.  Cyclosporine trough concentration monitoring in liver transplant patients.

Authors:  G J Burckart; R J Ptachcinski; R Venkataramanan; S Iwatsuki; C Esquivel; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

8.  Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.

Authors:  G J Burckart; R Venkataramanan; R J Ptachcinski; T E Starzl; B P Griffith; T R Hakala; J T Rosenthal; R L Hardesty; S Iwatsuki; J Brady
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

9.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  L Vernillet; P Bertault-Peres; Y Berland; J Barradas; A Durand; M Olmer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

10.  Interaction between roxithromycin and cyclosporin in heart transplant patients.

Authors:  E M Billaud; R Guillemain; N Fortineau; M D Kitzis; G Dreyfus; C Amrein; C Kreft-Jaïs; J M Husson; P Chrétien
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.